Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 USD | -0.18% | -17.49% | -11.06% |
Mar. 18 | Allogene Therapeutics, Inc.(NasdaqGS:ALLO) added to S&P Biotechnology Select Industry Index | CI |
Mar. 15 | Allogene Therapeutics Files $500 Million Mixed Shelf | MT |
Financials (USD)
Sales 2024 * | 42.75K | Sales 2025 * | 4.12M | Capitalization | 487M |
---|---|---|---|---|---|
Net income 2024 * | -283M | Net income 2025 * | -305M | EV / Sales 2024 * | 5,554 x |
Net cash position 2024 * | 250M | Net cash position 2025 * | 284M | EV / Sales 2025 * | 49.4 x |
P/E ratio 2024 * |
-1.7
x | P/E ratio 2025 * |
-1.72
x | Employees | 233 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.81% |
Latest transcript on Allogene Therapeutics, Inc.
1 day | -6.09% | ||
1 week | -17.49% | ||
Current month | -36.13% | ||
1 month | -33.45% | ||
3 months | -10.78% | ||
6 months | +7.33% | ||
Current year | -11.06% |
Managers | Title | Age | Since |
---|---|---|---|
Joshua Kazam
FOU | Founder | 47 | 17-10-31 |
David Chang
FOU | Founder | 64 | 18-03-31 |
Geoffrey Parker
DFI | Director of Finance/CFO | 59 | 23-10-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Bonderman
BRD | Director/Board Member | 81 | 18-04-30 |
Joshua Kazam
FOU | Founder | 47 | 17-10-31 |
Arie Belldegrun
FOU | Founder | 74 | 17-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.54% | 2 M€ | -25.75% | ||
0.08% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 2.855 | -6.09% | 2 772 870 |
24-04-24 | 3.04 | -9.79% | 2,108,440 |
24-04-23 | 3.37 | -0.88% | 1,606,762 |
24-04-22 | 3.4 | -2.02% | 1,789,993 |
24-04-19 | 3.47 | +0.29% | 2,013,218 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.06% | 487M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.55% | 22.02B | |
-17.84% | 20.9B | |
-9.30% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- ALLO Stock